ID   CYLD_RAT                Reviewed;         953 AA.
AC   Q66H62;
DT   18-MAR-2008, integrated into UniProtKB/Swiss-Prot.
DT   11-OCT-2004, sequence version 1.
DT   02-OCT-2024, entry version 137.
DE   RecName: Full=Ubiquitin carboxyl-terminal hydrolase CYLD;
DE            EC=3.4.19.12 {ECO:0000250|UniProtKB:Q9NQC7};
DE   AltName: Full=Deubiquitinating enzyme CYLD;
DE   AltName: Full=Ubiquitin thioesterase CYLD;
DE   AltName: Full=Ubiquitin-specific-processing protease CYLD;
GN   Name=Cyld; Synonyms=Cyld1;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [2]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-415 AND SER-419, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
CC   -!- FUNCTION: Deubiquitinase that specifically cleaves 'Lys-63'- and linear
CC       'Met-1'-linked polyubiquitin chains and is involved in NF-kappa-B
CC       activation and TNF-alpha-induced necroptosis. Negatively regulates NF-
CC       kappa-B activation by deubiquitinating upstream signaling factors.
CC       Contributes to the regulation of cell survival, proliferation and
CC       differentiation via its effects on NF-kappa-B activation. Negative
CC       regulator of Wnt signaling. Inhibits HDAC6 and thereby promotes
CC       acetylation of alpha-tubulin and stabilization of microtubules. Plays a
CC       role in the regulation of microtubule dynamics, and thereby contributes
CC       to the regulation of cell proliferation, cell polarization, cell
CC       migration, and angiogenesis. Required for normal cell cycle progress
CC       and normal cytokinesis. Inhibits nuclear translocation of NF-kappa-B.
CC       Plays a role in the regulation of inflammation and the innate immune
CC       response, via its effects on NF-kappa-B activation (By similarity).
CC       Dispensable for the maturation of intrathymic natural killer cells, but
CC       required for the continued survival of immature natural killer cells.
CC       Negatively regulates TNFRSF11A signaling and osteoclastogenesis.
CC       Involved in the regulation of ciliogenesis, allowing ciliary basal
CC       bodies to migrate and dock to the plasma membrane; this process does
CC       not depend on NF-kappa-B activation (By similarity). Ability to remove
CC       linear ('Met-1'-linked) polyubiquitin chains regulates innate immunity
CC       and TNF-alpha-induced necroptosis: recruited to the LUBAC complex via
CC       interaction with SPATA2 and restricts linear polyubiquitin formation on
CC       target proteins. Regulates innate immunity by restricting linear
CC       polyubiquitin formation on RIPK2 in response to NOD2 stimulation (By
CC       similarity). Involved in TNF-alpha-induced necroptosis by removing
CC       linear ('Met-1'-linked) polyubiquitin chains from RIPK1, thereby
CC       regulating the kinase activity of RIPK1 (By similarity). Negatively
CC       regulates intestinal inflammation by removing 'Lys-63' linked
CC       polyubiquitin chain of NLRP6, thereby reducing the interaction between
CC       NLRP6 and PYCARD/ASC and formation of the NLRP6 inflammasome (By
CC       similarity). Removes 'Lys-63' linked polyubiquitin chain of MAP3K7,
CC       which inhibits phosphorylation and blocks downstream activation of the
CC       JNK-p38 kinase cascades (By similarity). Removes also 'Lys-63'-linked
CC       polyubiquitin chains of MAP3K1 and MA3P3K3, which inhibit their
CC       interaction with MAP2K1 and MAP2K2 (By similarity).
CC       {ECO:0000250|UniProtKB:Q80TQ2, ECO:0000250|UniProtKB:Q9NQC7}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=Thiol-dependent hydrolysis of ester, thioester, amide, peptide
CC         and isopeptide bonds formed by the C-terminal Gly of ubiquitin (a 76-
CC         residue protein attached to proteins as an intracellular targeting
CC         signal).; EC=3.4.19.12; Evidence={ECO:0000250|UniProtKB:Q9NQC7};
CC   -!- SUBUNIT: Interacts (via CAP-Gly domain) with IKBKG/NEMO (via proline-
CC       rich C-terminal region). Interacts with TRAF2 and TRIP. Interacts with
CC       PLK1, DVL1, DVL3, MAVS, TBK1, IKKE and RIGI. Interacts (via CAP-Gly
CC       domain) with microtubules. Interacts with HDAC6 and BCL3 (By
CC       similarity). Interacts with MAP3K7. Identified in a complex with TRAF6
CC       and SQSTM1 (By similarity). Interacts with OPTN and SQSTM1 (By
CC       similarity). Interacts with CEP350. Interacts with RNF31; the
CC       interaction is indirect and is mediated via SPATA2. Interacts with
CC       SPATA2 (via the PUB domain); the interaction is direct and recruits
CC       CYLD to the LUBAC complex, thereby regulating TNF-alpha-induced
CC       necroptosis (By similarity). {ECO:0000250|UniProtKB:Q80TQ2,
CC       ECO:0000250|UniProtKB:Q9NQC7}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm. Cytoplasm, perinuclear region.
CC       Cytoplasm, cytoskeleton. Cell membrane {ECO:0000250|UniProtKB:Q9NQC7};
CC       Peripheral membrane protein {ECO:0000250|UniProtKB:Q9NQC7}; Cytoplasmic
CC       side {ECO:0000250|UniProtKB:Q9NQC7}. Cytoplasm, cytoskeleton,
CC       microtubule organizing center, centrosome
CC       {ECO:0000250|UniProtKB:Q9NQC7}. Cytoplasm, cytoskeleton, spindle
CC       {ECO:0000250|UniProtKB:Q9NQC7}. Cytoplasm, cytoskeleton, cilium basal
CC       body {ECO:0000250|UniProtKB:Q80TQ2}. Note=Detected at the microtubule
CC       cytoskeleton during interphase (By similarity). Detected at the midbody
CC       during telophase (By similarity). During metaphase, it remains
CC       localized to the centrosome but is also present along the spindle (By
CC       similarity). {ECO:0000250|UniProtKB:Q80TQ2,
CC       ECO:0000250|UniProtKB:Q9NQC7}.
CC   -!- PTM: Phosphorylated on several serine residues by IKKA and/or IKKB in
CC       response to immune stimuli. Phosphorylation requires IKBKG.
CC       Phosphorylation abolishes TRAF2 deubiquitination, interferes with the
CC       activation of Jun kinases, and strongly reduces CD40-dependent gene
CC       activation by NF-kappa-B (By similarity).
CC       {ECO:0000250|UniProtKB:Q9NQC7}.
CC   -!- PTM: Ubiquitinated. Polyubiquitinated in hepatocytes treated with
CC       palmitic acid. Ubiquitination is mediated by E3 ligase TRIM47 and leads
CC       to proteasomal degradation. {ECO:0000250|UniProtKB:Q80TQ2,
CC       ECO:0000250|UniProtKB:Q9NQC7}.
CC   -!- SIMILARITY: Belongs to the peptidase C19 family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; BC082001; AAH82001.1; -; mRNA.
DR   RefSeq; NP_001017380.1; NM_001017380.1.
DR   AlphaFoldDB; Q66H62; -.
DR   SMR; Q66H62; -.
DR   BioGRID; 260280; 3.
DR   STRING; 10116.ENSRNOP00000018888; -.
DR   MEROPS; C67.001; -.
DR   iPTMnet; Q66H62; -.
DR   PhosphoSitePlus; Q66H62; -.
DR   PaxDb; 10116-ENSRNOP00000018888; -.
DR   GeneID; 312937; -.
DR   KEGG; rno:312937; -.
DR   AGR; RGD:1308346; -.
DR   CTD; 1540; -.
DR   RGD; 1308346; Cyld.
DR   eggNOG; KOG3556; Eukaryota.
DR   InParanoid; Q66H62; -.
DR   OrthoDB; 5397179at2759; -.
DR   PhylomeDB; Q66H62; -.
DR   Reactome; R-RNO-168638; NOD1/2 Signaling Pathway.
DR   Reactome; R-RNO-5357786; TNFR1-induced proapoptotic signaling.
DR   Reactome; R-RNO-5357905; Regulation of TNFR1 signaling.
DR   Reactome; R-RNO-5357956; TNFR1-induced NF-kappa-B signaling pathway.
DR   Reactome; R-RNO-5689880; Ub-specific processing proteases.
DR   Reactome; R-RNO-936440; Negative regulators of DDX58/IFIH1 signaling.
DR   PRO; PR:Q66H62; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0005813; C:centrosome; ISS:UniProtKB.
DR   GO; GO:0036064; C:ciliary basal body; ISS:UniProtKB.
DR   GO; GO:0097542; C:ciliary tip; ISS:UniProtKB.
DR   GO; GO:0005881; C:cytoplasmic microtubule; ISO:RGD.
DR   GO; GO:0009898; C:cytoplasmic side of plasma membrane; ISO:RGD.
DR   GO; GO:0005829; C:cytosol; ISS:UniProtKB.
DR   GO; GO:0098978; C:glutamatergic synapse; IDA:SynGO.
DR   GO; GO:0030496; C:midbody; ISO:RGD.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0014069; C:postsynaptic density; IDA:SynGO.
DR   GO; GO:0005819; C:spindle; ISS:UniProtKB.
DR   GO; GO:0004843; F:cysteine-type deubiquitinase activity; ISS:UniProtKB.
DR   GO; GO:1990380; F:K48-linked deubiquitinase activity; ISO:RGD.
DR   GO; GO:0061578; F:K63-linked deubiquitinase activity; ISS:UniProtKB.
DR   GO; GO:0061815; F:Met1-linked polyubiquitin deubiquitinase activity; ISO:RGD.
DR   GO; GO:0070064; F:proline-rich region binding; ISO:RGD.
DR   GO; GO:0019901; F:protein kinase binding; ISO:RGD.
DR   GO; GO:0008270; F:zinc ion binding; ISS:UniProtKB.
DR   GO; GO:0043369; P:CD4-positive or CD8-positive, alpha-beta T cell lineage commitment; ISO:RGD.
DR   GO; GO:0048872; P:homeostasis of number of cells; ISO:RGD.
DR   GO; GO:0045087; P:innate immune response; ISS:UniProtKB.
DR   GO; GO:0070266; P:necroptotic process; ISO:RGD.
DR   GO; GO:0090090; P:negative regulation of canonical Wnt signaling pathway; ISS:UniProtKB.
DR   GO; GO:0050728; P:negative regulation of inflammatory response; ISS:UniProtKB.
DR   GO; GO:2000493; P:negative regulation of interleukin-18-mediated signaling pathway; ISS:UniProtKB.
DR   GO; GO:0046329; P:negative regulation of JNK cascade; ISS:UniProtKB.
DR   GO; GO:0032088; P:negative regulation of NF-kappaB transcription factor activity; ISS:UniProtKB.
DR   GO; GO:1901223; P:negative regulation of non-canonical NF-kappaB signal transduction; ISS:UniProtKB.
DR   GO; GO:1903753; P:negative regulation of p38MAPK cascade; ISS:UniProtKB.
DR   GO; GO:2001238; P:positive regulation of extrinsic apoptotic signaling pathway; ISO:RGD.
DR   GO; GO:1903829; P:positive regulation of protein localization; ISO:RGD.
DR   GO; GO:0045582; P:positive regulation of T cell differentiation; ISO:RGD.
DR   GO; GO:0050862; P:positive regulation of T cell receptor signaling pathway; ISO:RGD.
DR   GO; GO:0016579; P:protein deubiquitination; ISS:UniProtKB.
DR   GO; GO:0070536; P:protein K63-linked deubiquitination; IBA:GO_Central.
DR   GO; GO:1990108; P:protein linear deubiquitination; ISS:UniProtKB.
DR   GO; GO:0006508; P:proteolysis; IEA:UniProtKB-KW.
DR   GO; GO:0045577; P:regulation of B cell differentiation; ISO:RGD.
DR   GO; GO:1902017; P:regulation of cilium assembly; ISS:UniProtKB.
DR   GO; GO:0050727; P:regulation of inflammatory response; ISS:UniProtKB.
DR   GO; GO:2001242; P:regulation of intrinsic apoptotic signaling pathway; ISO:RGD.
DR   GO; GO:0070507; P:regulation of microtubule cytoskeleton organization; ISO:RGD.
DR   GO; GO:0007346; P:regulation of mitotic cell cycle; ISO:RGD.
DR   GO; GO:0060544; P:regulation of necroptotic process; ISO:RGD.
DR   GO; GO:0098696; P:regulation of neurotransmitter receptor localization to postsynaptic specialization membrane; IDA:SynGO.
DR   GO; GO:0010803; P:regulation of tumor necrosis factor-mediated signaling pathway; ISS:UniProtKB.
DR   GO; GO:0140252; P:regulation protein catabolic process at postsynapse; IDA:SynGO.
DR   GO; GO:1901026; P:ripoptosome assembly involved in necroptotic process; ISO:RGD.
DR   GO; GO:0016055; P:Wnt signaling pathway; IEA:UniProtKB-KW.
DR   CDD; cd02670; Peptidase_C19N; 1.
DR   Gene3D; 2.30.30.190; CAP Gly-rich-like domain; 3.
DR   Gene3D; 3.90.70.10; Cysteine proteinases; 1.
DR   InterPro; IPR036859; CAP-Gly_dom_sf.
DR   InterPro; IPR000938; CAP-Gly_domain.
DR   InterPro; IPR038765; Papain-like_cys_pep_sf.
DR   InterPro; IPR001394; Peptidase_C19_UCH.
DR   InterPro; IPR018200; USP_CS.
DR   InterPro; IPR028889; USP_dom.
DR   PANTHER; PTHR11830; 40S RIBOSOMAL PROTEIN S3A; 1.
DR   PANTHER; PTHR11830:SF15; UBIQUITIN CARBOXYL-TERMINAL HYDROLASE CYLD; 1.
DR   Pfam; PF01302; CAP_GLY; 2.
DR   Pfam; PF16607; CYLD_phos_site; 1.
DR   Pfam; PF00443; UCH; 1.
DR   SMART; SM01052; CAP_GLY; 3.
DR   SUPFAM; SSF74924; Cap-Gly domain; 3.
DR   SUPFAM; SSF54001; Cysteine proteinases; 1.
DR   PROSITE; PS00845; CAP_GLY_1; 1.
DR   PROSITE; PS50245; CAP_GLY_2; 2.
DR   PROSITE; PS00972; USP_1; 1.
DR   PROSITE; PS50235; USP_3; 1.
PE   1: Evidence at protein level;
KW   Cell membrane; Cell projection; Cytoplasm; Cytoskeleton; Hydrolase;
KW   Immunity; Innate immunity; Membrane; Metal-binding; Microtubule;
KW   Phosphoprotein; Protease; Reference proteome; Repeat; Thiol protease;
KW   Ubl conjugation; Ubl conjugation pathway; Wnt signaling pathway; Zinc.
FT   CHAIN           1..953
FT                   /note="Ubiquitin carboxyl-terminal hydrolase CYLD"
FT                   /id="PRO_0000326149"
FT   DOMAIN          153..198
FT                   /note="CAP-Gly 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00045"
FT   DOMAIN          253..286
FT                   /note="CAP-Gly 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00045"
FT   DOMAIN          489..532
FT                   /note="CAP-Gly 3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00045"
FT   DOMAIN          589..947
FT                   /note="USP"
FT   REGION          106..590
FT                   /note="Interaction with TRIP"
FT                   /evidence="ECO:0000250|UniProtKB:Q9NQC7"
FT   REGION          318..350
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          387..410
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          391..466
FT                   /note="Interaction with TRAF2"
FT                   /evidence="ECO:0000250|UniProtKB:Q9NQC7"
FT   REGION          467..681
FT                   /note="Interaction with IKBKG/NEMO"
FT                   /evidence="ECO:0000250|UniProtKB:Q9NQC7"
FT   REGION          778..830
FT                   /note="B-box"
FT                   /evidence="ECO:0000250|UniProtKB:Q9NQC7"
FT   COMPBIAS        325..350
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   ACT_SITE        598
FT                   /note="Nucleophile"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU10092"
FT   ACT_SITE        868
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU10092"
FT   BINDING         785
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000250|UniProtKB:Q9NQC7"
FT   BINDING         788
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000250|UniProtKB:Q9NQC7"
FT   BINDING         796
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000250|UniProtKB:Q9NQC7"
FT   BINDING         799
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000250|UniProtKB:Q9NQC7"
FT   BINDING         814
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000250|UniProtKB:Q9NQC7"
FT   BINDING         817
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000250|UniProtKB:Q9NQC7"
FT   BINDING         822
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000250|UniProtKB:Q9NQC7"
FT   BINDING         830
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000250|UniProtKB:Q9NQC7"
FT   MOD_RES         384
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9NQC7"
FT   MOD_RES         415
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         419
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
SQ   SEQUENCE   953 AA;  106713 MW;  573B59E9BD795252 CRC64;
     MSSGLWNQEK VTSPYWEERL FYLLLQECSV TDKQTQKLLR VPKGSIGQYI QDRSVGHSRV
     PSAKGKKNQI GLKILEQPHA VLFVDEKDVV EINEKFTELL LAITNCEERL SLFRNRIRLS
     KGLQVDVGSP VRVQLRSGEE KFPGVVRFRG PLLAERTVSG IFFGVELLEE GRGQGFTDGV
     YQGKQLFQCD EDCGVFVALD KLELIEDDDN GLESDFAGPG DTVQVEPPPL EINSRVSLKV
     GESTESGTVI FCDVLPGKES LGYFVGVDMD NPIGNWDGRF DGVQLCSFAS VESTVLLHIN
     DIIPDSVTQE RRPPKLAFMS RGVGDKGSSS HNKPKVTGST SDPGSRNRSE LFYTLNGSSV
     DSQQQSKSKN PWYIDEVAED PAKSLTEMSS DFGHSSPPPQ PPSMNSLSSE NRFHSLPFSL
     TKMPNTNGSM AHSPLSLSVQ SVMGELNSTP VQESPPMPSS SGNAHGLEVG SLAEVKENPP
     FYGVIRWIGQ PPGLSDVLAG LELEDECAGC TDGTFRGTRY FTCALKKALF VKLKSCRPDS
     RFASLQPVSN QIERCNSLAF GGYLSEVVEE NTPPKMEKEG LEIMIGKKKG IQGHYNSCYL
     DSTLFCLFAF SSALDTVLLR PKEKNDVEYY SETQELLRTE IVNPLRIYGY VCATKIMKLR
     KILEKVEAAS GFTSEEKDPE EFLNILFHDI LRVEPLLKIR SAGQKVQDCN FYQIFMEKNE
     KVGVPTIQQL LEWSFINSNL KFAEAPSCLI IQMPRFGKDF KLFKKIFPSL ELNITDLLED
     TPRQCRICGG LAMYECRECY DDPDISAGKI KQFCKTCSTQ VHLHPRRLNH TYHPVSLPKD
     LPDWDWRHGC IPCQKMELFA VLCIETSHYV AFVKYGKDDS AWLFFDSMAD RDGGQNGFNI
     PQVTPCPEVG EYLKMSLEDL HSLDSRRIQG CARRLLCDAY MCMYQSPTMS LYK
//
